The landscape of medical research is shifting: rare disease patient advocates are no longer just participants, they are the architects of discovery. Driven by an urgent need for life-saving treatments, these leaders are spearheading research initiatives with unprecedented momentum. To support this movement, Global Genes (IRDiRC Patient Advocates Constituent Committee member), in partnership with Boston […]
Read More
